ConductScience.org, home

Paper3907322

Effects of diltiazem on serum lipids, exercise performance and blood pressure: randomized, double-blind, placebo-controlled evaluation for systemic hypertension.

Pool PE and 2 others. Am J Cardiol, 1985. Cited by 97 papers, by iCite.

Cite this record

ConductScience Library. Effects of diltiazem on serum lipids, exercise performance and blood pressure: randomized, double-blind, placebo-controlled evaluation for systemic hypertension. Papers, record 3907322. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3907322

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effects of diltiazem on serum lipids, exercise performance and blood pressure: randomized, double-blind, placebo-controlled evaluation for systemic hypertension.
PubMed
Journal
Am J Cardiol
PubMed
Year
1985
PubMed
Publication types
Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
97
iCite
Relative citation ratio, by iCite
5.44
iCite
Revised in PubMed
2019-06-22
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Pool PEP E
2Seagren SCS C
3Salel AFA F

Source PubMed

Download CSV of authors

Topics20

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
BenzazepinesMajor topic
Blood PressureMajor topic
DiltiazemMajor topic
HypertensionMajor topic
LipidsMajor topic
Physical ExertionMajor topic
Cholesterol
Clinical Trials as Topic
Delayed-Action Preparations
Double-Blind Method
Exercise Test
Female
Heart Rate
Humans
Male
Middle Aged
Prospective Studies
Random Allocation
Time Factors
Triglycerides

Source PubMed

Download CSV of topics

Cited by17

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 97 citations.

PMIDTitleJournalYearIn PapersSource
28947046Frailty and maximal exercise capacity in adult lung transplant candidates.Respir Med2017https://conductscience.org/library/papers/28947046PubMed
27739019Hypertension in Athletes and Active Populations.Curr Hypertens Rep2016https://conductscience.org/library/papers/27739019PubMed
24956970A randomized controlled trial of the effects of aerobic dance training on blood lipids among individuals with hypertension on a thiazide.High Blood Press Cardiovasc Prev2014https://conductscience.org/library/papers/24956970PubMed
23100862A comparative study on the effects of Gemfibrozil, Diltiazem and Isosorbide dinitrate on lipid profile in patients of ischemic heart disease in India.Indian J Clin Biochem1997https://conductscience.org/library/papers/23100862PubMed
12797840Exercise in hypertension. A clinical review.Sports Med2003https://conductscience.org/library/papers/12797840PubMed
8369596Diltiazem. A review of its pharmacology and therapeutic use in older patients.Drugs Aging1993https://conductscience.org/library/papers/8369596PubMed
7512479Influence of antihypertensive drugs on exercise capacity.Drugs1993https://conductscience.org/library/papers/7512479PubMed
3319640Comparison of nicardipine and propranolol in the treatment of mild and moderate hypertension.Eur J Clin Pharmacol1987https://conductscience.org/library/papers/3319640PubMed
3042351Serum lipoproteins during treatment with antihypertensive drugs.Drugs1988https://conductscience.org/library/papers/3042351PubMed
2904883Effect of calcium channel blockade and beta-adrenoceptor blockade on short graded and single-level endurance exercises in normal men.Eur J Appl Physiol Occup Physiol1988https://conductscience.org/library/papers/2904883PubMed
2877846The effects of antihypertensive drugs on serum lipids and lipoproteins. II. Non-diuretic drugs.Drugs1986https://conductscience.org/library/papers/2877846PubMed
2191851Diltiazem. A reappraisal of its pharmacological properties and therapeutic use.Drugs1990https://conductscience.org/library/papers/2191851PubMed
2083193Antihypertensive monotherapy with tablet (prompt-release) diltiazem: multicenter controlled trials.Cardiovasc Drugs Ther1990https://conductscience.org/library/papers/2083193PubMed
2076733A comparison of diltiazem and metoprolol in hypertension. Swedish Diltiazem-Metoprolol Multicentre Study Group.Eur J Clin Pharmacol1990https://conductscience.org/library/papers/2076733PubMed
2076390Effects of short- and long-term administration of nifedipine on serum lipoprotein metabolism in patients with mild hypertension.Cardiovasc Drugs Ther1990https://conductscience.org/library/papers/2076390PubMed
1888693Twenty-four hour ambulatory blood pressure profile of a new slow-release formulation of diltiazem in mild to moderate hypertension.Cardiovasc Drugs Ther1991https://conductscience.org/library/papers/1888693PubMed
1450091A multicenter comparison of nicorandil and diltiazem on serum lipid, apolipoprotein, and lipoprotein levels in patients with ischemic heart disease.Cardiovasc Drugs Ther1992https://conductscience.org/library/papers/1450091PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3907322

GET https://conductscience.org/api/papers/v1/3907322/authors